MKGAF MERCK KGAA
- 193.000
- +8.279+4.48%
- 186.221
- -6.779-3.51%
MERCK KGAA News
European Exporters With Stretched Valuations - JPM
Merck KGaA Reports Q2 Results
ASNA and Athinia Collaborate to Boost Semiconductor Manufacturing Yields Through Improved Data Sharing and Traceability of Subcomponent Parts
Merck KGaA Falls After Discontinuing Head and Neck Cancer Therapy
Express News | CORRECTION: Merck KGaA Ticker Is "MKGAF"
'Merck KGaA: Phase III Trials of Xevinapant in Locally Advanced Head & Neck Cancer Discontinued'
Merck KGaA's (ETR:MRK) Stock Has Fared Decently: Is the Market Following Strong Financials?
J.P. Morgan's Top Picks Within Defensives
Merck KGaA Invests in Life Science Business Facility in Germany
Merck KGaA to Build EUR62 Million Facility for Life Science Business
Merck KGaA Completes EUR180 Million German Distribution Center Expansion
Merck KGaA to Launch New Clinical Studies for Oncology Pipeline
Biolojic Design Enters Into a Multi-Target Drug Discovery Collaboration With Merck KGaA, Darmstadt, Germany
Emerging and Chinese Pharmas Playing Greater Role in Oncology Drug Development
Merck KGaA Signs Korea Science Research Pact
Merck KGaA Teams up With South Korean University to Support Life Sciences Research
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
Analysts' Top Healthcare Picks: Merck KGaA (GB:0O14), Paragon Care Limited (DE:PXS)
MilliporeSigma Launches First Software for Complete Data Traceability in Microbial Quality Control
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 29%?
Analysis
Price Target
No Data
No Data